Efficacy and safety from a phase 2B trial of SM04690, a novel, intra-articular, WNT pathway inhibitor for the treatment of osteoarthritis of the knee
Saved in:
Published in | Osteoarthritis and cartilage Vol. 27; p. S503 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.04.2019
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!